Acura Pharmaceuticals Operating Margin 2012-2021 | ACUR
Current and historical operating margin for Acura Pharmaceuticals (ACUR) over the last 10 years. The current operating profit margin for Acura Pharmaceuticals as of December 31, 2021 is 0.00%.
| Acura Pharmaceuticals Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2021-12-31 | $0.00B | $0.00B | -50.00% |
| 2021-09-30 | $0.00B | $0.00B | -33.33% |
| 2021-06-30 | $0.00B | $0.00B | -33.33% |
| 2021-03-31 | $0.00B | $0.00B | -33.33% |
| 2020-12-31 | $0.00B | $0.00B | -33.33% |
| 2020-09-30 | $0.00B | $0.00B | -33.33% |
| 2020-06-30 | $0.00B | 0 | 0.00% |
| 2020-03-31 | $0.00B | $0.00B | -33.33% |
| 2019-12-31 | $0.00B | $0.00B | -100.00% |
| 2019-09-30 | $0.00B | $0.00B | -200.00% |
| 2019-06-30 | $0.00B | $0.00B | 0.00% |
| 2019-03-31 | $0.00B | $0.00B | 0.00% |
| 2018-12-31 | $0.00B | $0.00B | 0.00% |
| 2018-09-30 | $0.00B | $-0.01B | 0.00% |
| 2018-06-30 | $0.00B | $-0.01B | 0.00% |
| 2018-03-31 | $0.00B | $-0.01B | 0.00% |
| 2017-12-31 | $0.00B | $-0.01B | -166.67% |
| 2017-09-30 | $0.01B | $0.00B | -14.29% |
| 2017-06-30 | $0.01B | $0.00B | -14.29% |
| 2017-03-31 | $0.01B | $0.00B | -28.57% |
| 2016-12-31 | $0.00B | $-0.01B | -150.00% |
| 2016-09-30 | $0.00B | $-0.01B | -300.00% |
| 2016-06-30 | $0.00B | $-0.01B | -300.00% |
| 2016-03-31 | $0.00B | $-0.01B | -266.67% |
| 2015-12-31 | $0.01B | $0.00B | -37.50% |
| 2015-09-30 | $0.01B | $0.00B | -66.67% |
| 2015-06-30 | $0.01B | $-0.01B | -83.33% |
| 2015-03-31 | $0.01B | $-0.01B | -100.00% |
| 2014-12-31 | $0.00B | $-0.01B | -1200.00% |
| 2014-09-30 | $0.00B | $-0.01B | 0.00% |
| 2014-06-30 | $0.00B | $-0.01B | 0.00% |
| 2014-03-31 | $0.00B | $-0.01B | 0.00% |
| 2013-12-31 | $0.00B | $-0.01B | 0.00% |
| 2011-12-31 | $0.02B | $0.01B | 50.00% |
| 2011-06-30 | $0.02B | $0.01B | 40.00% |
| 2011-03-31 | $0.00B | $-0.01B | -1200.00% |
| 2010-12-31 | $0.00B | $-0.01B | -433.33% |
| 2010-09-30 | $0.00B | $-0.01B | -350.00% |
| 2010-06-30 | $0.01B | $-0.02B | -300.00% |
| 2010-03-31 | $0.01B | $-0.02B | -300.00% |
| 2009-12-31 | $0.00B | $-0.01B | -325.00% |
| 2009-09-30 | $0.01B | $-0.01B | -72.73% |
| 2009-06-30 | $0.01B | $-0.01B | -50.00% |
| 2009-03-31 | $0.03B | $0.01B | 24.14% |
| 2008-12-31 | $0.05B | $0.02B | 46.67% |
| 2004-06-30 | $0.00B | $-0.03B | -700.00% |
| 2004-03-31 | $0.01B | $-0.02B | -420.00% |
| 2003-12-31 | $0.01B | $-0.02B | -283.33% |
| 2003-09-30 | $0.01B | $-0.02B | -400.00% |
| 2003-06-30 | $0.01B | $-0.02B | -300.00% |
| 2003-03-31 | $0.01B | $-0.02B | -225.00% |
| 2002-12-31 | $0.01B | $-0.01B | -162.50% |
| 2002-09-30 | $0.01B | $-0.02B | -275.00% |
| 2002-06-30 | $0.01B | $-0.02B | -145.45% |
| 2002-03-31 | $0.01B | $-0.01B | -127.27% |
| 2001-12-31 | $0.02B | $-0.01B | -52.94% |
| 2001-09-30 | $0.02B | $-0.01B | -44.44% |
| 2001-06-30 | $0.02B | $-0.01B | -55.56% |
| 2001-03-31 | $0.03B | $0.00B | -16.00% |
| 2000-12-31 | $0.02B | $-0.01B | -40.00% |
| 2000-09-30 | $0.02B | $-0.01B | -45.00% |
| 2000-06-30 | $0.02B | $-0.01B | -58.82% |
| 2000-03-31 | $0.01B | $-0.02B | -136.36% |
| 1999-12-31 | $0.01B | $-0.01B | -127.27% |
| 1999-09-30 | $0.01B | $-0.01B | -109.09% |
| 1999-06-30 | $0.01B | $-0.01B | -100.00% |
| 1999-03-31 | $0.01B | $-0.01B | -110.00% |
| 1998-12-31 | $0.01B | $-0.01B | -133.33% |
| 1998-09-30 | $0.01B | $-0.01B | -87.50% |
| 1998-06-30 | $0.01B | $0.00B | -37.50% |
| 1998-03-31 | $0.01B | $0.00B | -37.50% |
| 1997-12-31 | $0.01B | $0.00B | -33.33% |
| 1997-09-30 | $0.01B | $-0.01B | -88.89% |
| 1997-06-30 | $0.01B | $-0.02B | -240.00% |
| 1997-03-31 | $0.01B | $-0.02B | -218.18% |
| 1996-12-31 | $0.01B | $-0.02B | -183.33% |
| 1996-09-30 | $0.01B | $-0.01B | -64.29% |
| 1996-06-30 | $0.02B | $-0.01B | -46.67% |
| 1996-03-31 | $0.02B | $0.00B | -23.53% |
| 1995-12-31 | $0.02B | $0.00B | -15.00% |
| 1995-09-30 | $0.02B | $-0.02B | -104.55% |
| 1995-06-30 | $0.02B | $-0.01B | -58.33% |
| 1995-03-31 | $0.03B | $-0.01B | -40.00% |
| 1994-12-31 | $0.03B | $0.00B | -16.00% |
| 1994-09-30 | $0.03B | $0.01B | 50.00% |
| 1994-06-30 | $0.03B | $0.02B | 76.92% |
| 1994-03-31 | $0.03B | $0.02B | 73.08% |
| 1993-12-31 | $0.03B | $0.01B | 42.42% |
| 1993-09-30 | $0.04B | $0.02B | 52.50% |
| 1993-06-30 | $0.05B | $0.02B | 40.43% |
| 1993-03-31 | $0.05B | $0.02B | 32.08% |
| 1992-12-31 | $0.05B | $0.02B | 34.00% |
| 1992-06-30 | $0.03B | $0.00B | 9.38% |
| 1992-03-31 | $0.03B | $0.00B | 10.34% |
| 1991-09-30 | $0.03B | $0.00B | 11.76% |
| 1991-06-30 | $0.03B | $0.00B | 12.90% |
| 1991-03-31 | $0.03B | $0.00B | 13.79% |
| 1990-12-31 | $0.03B | $0.00B | 11.11% |
| 1990-09-30 | $0.03B | $0.00B | 4.00% |
| 1990-06-30 | $0.02B | 0 | 0.00% |
| 1990-03-31 | $0.02B | 0 | 0.00% |
| 1989-12-31 | $0.02B | $0.00B | 4.76% |
| 1989-09-30 | $0.02B | $0.00B | 15.00% |
| 1989-06-30 | $0.02B | $0.00B | 21.05% |
| 1989-03-31 | $0.02B | $0.00B | 16.67% |
| 1988-12-31 | $0.02B | $0.00B | 11.76% |
| 1988-09-30 | $0.01B | $0.00B | 7.69% |
| 1988-06-30 | $0.01B | 0 | 0.00% |
| 1988-03-31 | $0.01B | 0 | 0.00% |
| 1987-12-31 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |